Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent ...

Traws Pharma (TRAW) announced that data supporting the potential for tivoxavir marboxil as a bird flu treatment was presented yesterday in a ...

Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 dataFull da ...

A new type of ‘vaccine scepticism’ has been uncovered by researchers at Lancaster University, who examined a nine-million-word corpus of tweets looking at vaccine comparisons and evaluations.

Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent ... have potent activity against difficult to treat or resistant virus strains ...

The flu virus is dangerous because it's a shape-shifter ... mutated in some unknown animal host before making the jump to humanity. The SARS epidemic is a poster child for worldwide public health ...

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and t ...

The USDA plans to repurpose some of the expected savings into addressing a bird flu outbreak that has led ... Eggs have become the poster child for an inflation rate that skyrocketed during ...

Traws Pharma, Inc. (NASDAQ: TRAW) shared encouraging findings on its investigational antiviral drug, tivoxavir marboxil (TXM) ...

We are advancing novel investigational antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human ... oral small molecules targeting bird flu ...